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Abstract  
This degree project in medicine, “An inquiry of Obstructive Jaundice at Tribhuvan University 
Teaching hospital, Kathmandu, Nepal” written by Sabina Delin, medical student at the 
University of Gothenburg, Sweden, 2018. 
Introduction: No previous studies have been made in Nepal concerning the causes and 
symptoms of obstructive jaundice. This study explores correlations between the disease and sex, 
age, underlying causes and symptoms. 
Method: The study consisted of two parts. The first was a retrospective study where one-
hundred-and-ten patients were included. Their medical records were used as a basis. The other 
was a prospective cross-sectional study where eighteen patients were included, of the one-
hundred-and-ten patients from the retrospective part. A patient form and their medical records 
were used to collect data.  
Results: Retrospective data: 110 patients were included. There were 61 (55.5 %) females and 
49 (44.5 %) males. About half of the patients had a malignant cause to the disease and half had a 
benign cause.  The mean age of the patients with malign cause was 61 years compared to the 
mean age of 47 years for those with benign cause. There was a difference of 14 - years in mean 
difference. The most common cause was distal cholangiocarcinoma (15.5%) followed by 
pancreatitis (13.6%). The most common presentation of obstructive jaundice (presented as 
percentage of how many patients had each symptom) was jaundice (79.1%), other symptoms 
(58.2%), RUQ - pain (40.9%), itching (38.2%), anorexia/loss of appetite/loss of weight (38.2%) 
and epigastric pain (37.3%. Prospective cross-sectional data: 18 patients were included, of 
these were 11 (61.1%) women and 7 (38.9%) men. There were 10 (55.6%) malign cases, 6 
(33.3%) benign cases and 2 (11.1%) patients with unknown cause. The mean age of the patients 
with malign cause was 62 years compared to the mean age of 34 years for those with benign 
 
 
 
 
cause. There was a difference of 28 years in mean difference. Hilar cholangiocarcinoma was the 
most common cause of all followed by bile duct injury. The presenting symptoms noted in the 
medical journals were jaundice 58.8 %, itching 41.2%, anorexia/weight loss/loss of appetite 
35.3%, RUQ - pain 35.3%, fever without chills 35.3%, clay-coloured stool 29.4%, other 
symptoms 29.4%, dark urine 17.6%, epigastric pain 17.6 % and fever with chills 5.9%. The 
symptoms found in the patient forms were jaundice 83.3%, itching 77.8%, RUQ - pain 55.6%, 
fever with chills and rigor 33.3%, clay-coloured stool 38.9% and dark urine 61.1%.  
Conclusions: It is more common for older people to have a malignant cause of obstructive 
jaundice. This study indicates other proportions of the malign spectrum, compared to 
comparative studies, with distal cholangiocarcinoma as the leading cause. It seems like 
cholangiocarcinoma is more common in Nepal compared to what studies have shown in 
neighbouring countries. This indicates a different pattern of care-seeking due to i.e. economic 
factors or that cholangiocarcinoma as a cause to obstructive jaundice is more common in Nepal 
and possibly has a hinger incidence in the Nepalese population.  
Keywords:  Obstructive Jaundice, Aetiology, Symptoms 
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1. Introduction  
This Degree Project, initiated by Prof. Singh, Chief surgeon at the Department of Surgery at 
T.U.T.H. is an attempt to elucidate this area of medicine from a Nepali perspective. 
1.1 Country background 
Nepal is situated in south Asia bordering to China in the north and to India in all other 
directions. Nepal has a diverse landscape with lowlands with its forests and forested watersheds 
to the Himalayas with mountains, alpine pastures and temperate forests and the inner Himalayan 
valley with cold deserts and rivers. The population is around 26 million people and comprises 
about 101 ethnic groups that speak more than 92 languages. The official language is Nepali (The 
Official Tourism Website for Nepal, 2017). The BNP per person is 732 US dollars in 2015 
(compared to 50 273 US dollars per person in Sweden). Thus, Nepal is a low-income country 
with a life expectancy at birth of 68 years (WHO, 2012). The literacy rate between the ages of 15-
24 years was 79.4 % in 2006 (Central bureau of statistics, 2007). 
However, during the last decades there has been a considerable improvement in economic 
status, demographic parameters and the health status of the population. As one of many 
examples the improvements made over the past 20 years in maternal and neonatal health has led 
to a decrease in mortality for children under five years from 142 to 40/1000 children. (WHO, 
2012). 
1.2 Health care system 
The access to health care for the entire population can be difficult, especially concerning the 
rural areas with difficult terrain where there are not as many hospitals or health posts. 
Still, most of the people have a health post within 30 minutes of travelling, but only a third have 
a public hospital within the same range (Roshan Khadka, Student at Mahidol University Follow, 
2016). The total expenditure on health per capita is 137 dollars (WHO, 2014) compared to 5. 219 
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dollars per capita in Sweden (WHO, 2014). At present, most of the expenditure regarding health 
care is financed by on-use basis. However, the government intends to make it more publicly 
funded in the future, especially for people with a low income as a first step (WHO: Country 
office for Nepal, 2007). 
Today, parts of the health care are free of charge i.e. immunization of children, deliveries at 
institutions, family planning services, treatment of heart, liver and kidney diseases and cancer at 
governmental hospitals. 70 kinds of essential drugs are provided free of charge as well as 
screening and treatment of TB and leprosy (Roshan Khadka, Student at Mahidol University 
Follow, 2016). The government plans to provide health insurance within three years to all Nepali 
citizen (Ghimire, 2017). 
1.3 The hospital 
Tribhuvan University Teaching Hospital (T.U.T.H.) is a non-profit hospital situated in 
Kathmandu. It was built in 1983 and provides medical care for the most needed. T.U.T.H. is an 
integrated part of the institute of medicine of Tribuhvan University and conducts medical 
research. It is a tertiary care hospital which with its 22 departments has the greatest number of 
specialities of any hospital in Nepal. It provided medical services to around 400 000 patients 
during the last year (Institute of Medicine, 2012). 
1.4 Obstructive jaundice as a disease 
Obstructive jaundice is a common surgical problem in the world and poses a challenge to 
surgeons, anaesthesiologists and intensive care teams. These patients need invasive techniques to 
relieve the obstruction in the bile tree and sometimes surgery that is associated with an elevated 
risk of complications and mortality. Obstructive jaundice patients are more pre-disposed to 
developing nutritional deficits, infectious complications, acute renal failure and impairment of 
cardiovascular function. They can suffer from coagulopathy, hypovolemia and endotoxemia, 
which can lead to significantly increased mortality and morbidity. 
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Cholestasis is a condition where there is an interruption in the excretion of bile. It can be divided 
into intrahepatic cholestasis, obstruction within the liver, and extrahepatic cholestasis, 
obstruction of the bile ducts outside the liver (K. Modha. 2015). There are two major functions 
of hepatic bile, it works as an emulsifier of dietary fat in the lumen of the gut through the 
detergent action of bile salts and helps to eliminate bilirubin, excess cholesterol and other waste 
products that are not enough water-soluble to be excreted though urine. (Robbins et al., 2010). 
When there is an obstruction it causes the bile salts, lipids and bilirubin to accumulate in the 
blood stream. Intrahepatic cholestasis can be caused by intrinsic parenchymal disorders such as 
Primary Biliary Cholangitis, hepatitis due to drugs and cystic fibrosis (K. Modha. 2015). 
Extrahepatic cholestasis is caused by a mechanical blockage. This could be due to gallstones, 
tumours in the bile ducts, pancreatic cancer or other conditions that cause increased pressure of 
the bile duct, such as scar tissue (from previous infection or surgery) or a cyst. (Robbins et al., 
2010). This obstruction of the bile ducts, named obstructive jaundice or previously surgical 
jaundice, can in rare cases be caused by the nematode Ascaris Lumbricoides (Khuroo, Rather, 
Khuroo, & Khuroo, 2016). The clinical manifestations of altered bile formation and flow are 
jaundice, a condition where conjugated bilirubin circulating in the blood stream dissolves in the 
subcutaneous fat which leads to a yellowish discoloration of the skin, sclera and mucous 
membranes. The benign cause is more common in young people opposed to the malignant cause 
that is more common in older people (K. Siddique. 2011). Extrahepatic obstruction of the bile 
channel, a mechanical blockage, is often possible to alleviate through surgery. Therefore, a 
correct and fast diagnosis is important. This contrasts with intrahepatic obstruction, caused by 
secretory failure of the hepatocytes which leads to disturbances in the bile formation. This 
condition is normally not benefited by surgery and it could even worsen the patient’s condition. 
(Robbins et al., 2010). 
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1.5 Obstructive jaundice research 
The incidence of obstructive jaundice in the population is not fully known today, due to lack of 
research in significant areas. The problem is especially large in developing countries, like Nepal, 
where quite often no studies have been made concerning the causes and symptoms of 
obstructive jaundice. Although, lessons can be learnt from similar studies on this topic from 
neighbouring countries such as India (Gupta, Singh, Goel & Tank, 2017) and Pakistan (Siddique, 
Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008). 
2. Aim  
The postoperative morbidity can be as high as 20-30% (Wang, Yu, 2013). The aetiology of the 
obstruction predicts and explains the differences in morbidity and mortality (Gupta, Singh, Goel 
& Tank, 2017). What could help us improve the management and treatment of patients with 
obstructive jaundice, if not a better understanding of the presenting symptoms and causes of 
obstructive jaundice? Quite often no studies have been made concerning the causes and 
symptoms of obstructive jaundice. This Degree Project is an attempt to elucidate this area from 
a Nepali perspective. 
3. Objective  
The objective was to describe the patients with obstructive jaundice at T.U.T.H. and initiating 
more research. 
The main question of this study regards “What are the proportions of different aetiologies of 
obstructive jaundice at T.U.T.H.?” 
To address this, other sub-questions were addressed as follows: 
 
• What are the demographic parameters like age, sex, urban – rural, ethnic background. 
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• Are there any correlations between age and sex?  
• What symptoms do the patients present with? Which was the first presenting symptom? 
•  How are the patients diagnosed? Are ultrasound, CT and MRI used?  
•  What are the methods of treatment? What are the purpose? Are there any complications? 
• How many days do the patients spend in the hospital?  
 
4. Material and methods 
The research study has taken place at the Department of surgery, T.U.T.H. Kathmandu, Nepal. 
4.1Retrospective part 
The first part of the study was a retrospective part using two methods to include patients. The 
first method was to go through the admittance books of the three surgical wards, the Female 
Surgical Ward (FSW), the Male Surgical Ward (MSW) and the Annex-1 Ward, starting from the 
Nepali date of 2074-1-1 until 2074-7-15 which corresponds to the English calendar of 14th April 
until the 1st October 2017. The admitted patients with any preliminary diagnosis that was 
connected to the bile duct system or any connected organ such as the liver, gall bladder or 
pancreas were searched. The diagnoses and words connected to the bile duct system, that can 
cause obstructive jaundice found in the admittance books were the following : symptomatic 
cholelithiasis, biliary colic, hilar and distal cholangiocarcinoma, gall bladder cancer, gall bladder 
polyp, ampulla of water cancer (pen ampullary and periampullary carcinoma), pancreatic 
carcinoma (head of pancreas cancer), biliary stricture, acute mild and severe cholangitis, acute 
cholecystitis, congenital structural defects, choledochal cysts, abdominal lymph node 
enlargement due to for example TB, acute and chronic pancreatitis, acute necrotising biliary 
pancreatitis, pancreatic pseudocysts, parasitic infection, blunt abdominal trauma and trauma 
including surgical complications such as bile duct injury, dislodged Percutaneous transhepatic 
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biliary drainage (PTBD), status post Whippel’s procedure, hepatocellular carcinoma, liver 
abscess, cystadenoma of the head of the pancreas and metastases in the connected area. The in-
patient number, name and preliminary diagnosis were written down. This list of patients was 
used to search firstly in the computerised medical records system after the discharge papers. 
Most of the patients that were found through this method could either easily be excluded or 
included depending on the information in the discharge papers. The patients were included 
based on clinical signs such as jaundice, biochemical parameters as an elevation of total and 
direct bilirubin, preferably with an ALP increase and radiological signs of dilated bile ducts where 
searched for. If the picture in general was that of an obstruction in the bile ducts, the patient was 
diagnosed with obstructive jaundice. When there was no information about jaundice, elevated 
bilirubin, elevated ALP or radiological signs of obstruction the patient was assumed not to have 
obstructive jaundice and was excluded. If there was something pointing to an obstruction and 
the case was unclear, attempts were made to find the medical record in the archive. After this 
process was completed the patients complete medical records were searched for, for those cases 
that could not be found in the computerised system or those that had incomplete records, in the 
medical records archives. Many medical records were lost and could not be found. All the 
medical records that could not be found in the archive were asked for at least two times. The 
medical records that were found were subject to the same inclusion and exclusion criteria’s. Data 
collection were performed using the collection form (Attachment C). This second form was 
produced solely for the collection of data, this form was designed by the author after researching 
the medical records. 
Furthermore, an expanded cross search was done in the computerized journal system for 
patients admitted, from the Nepali calendar date of 2074-1-1 until 2074-6-14 corresponding to 
the 14th April until the 1st October in the English calendar, at the surgical ward with the diagnosis 
of either obstructive jaundice, bile duct, bile duct injury, gallbladder, PTBD or 
 
 
7 
 
cholangiocarcinoma which led to that one more patient was included out of 54 patients that was 
found, 32 was already included and the rest could be excluded. 
In total there were 1855 patients in the admittance books between these dates. Out of these 
there were 503 patients that had a preliminary diagnosis that were determined to be of relevance. 
32 of these patients could not be found, either due to that the numbers in the admittance books 
were faulty or because the records could not be found in the medical archive. 342 patients were 
excluded since their medical records showed no signs of obstructive jaundice. 129 patients were 
found to have obstructive jaundice. Out of these obstructive jaundice cases, 10 were duplicates 
of the same patients and the same hospitalizations. Of the 119 remaining patients, 3 were in 
some essential aspect missing data and 18 was in-hospitalizations of the same patient at another 
time but with the same disease and were therefore excluded. 98 individual patient cases remained 
and were included in the study. 
The second method was to include patients from those found at the ward, taking part in the 
prospective part of the study (described below in section 5.2). This meant that additionally 12 
patients, which were not already included in the retrospective series, out of the 18 patients, could 
be included. This made a total of 110 patients in the retrospective part (Attachment D). 
4.2 Prospective cross-sectional part 
The second part of the study was a prospective cross-sectional part. A patient form was 
produced (Attachment A), focusing on symptoms and lifestyle factors. The form was translated 
into Nepali by the help of Google translate and further by corrections made by Dr Bikal 
Ghimire. The form was then corrected into its final form and printed by the office secretary. A 
Nepali consent form (Attachment B) was created after the adaptation of a model consent form 
with the addition of the study name, department and the name of the author. Patients were 
recruited using the same kind of criteria in accordance with the same principles as in the 
retrospective part of the study, using the same search words to find patients that could have 
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obstructive jaundice. The admittance books of the three surgical wards: MSW, FSW and the 
Annex-1 Ward were searched each morning that the author was present at the hospital. This was 
done starting from the 1st October until the 1st November. The room number of these patients 
were written down and their medical records were collected and searched after signs of 
obstructive jaundice. The same inclusion criteria were used as in the retrospective part. The 
patients that had obstructive jaundice were asked to be part of the study and fill out the patient 
form (Attachment A). The patients were asked to participate in the research study by asking 
them to read the consent form and the patient form and if needed they were given the 
opportunity to ask questions. They had the possibility to ask questions in Nepali by talking to a 
nurse working at the ward. Furthermore, the medical records of these patients were used to fill 
out the collection form (Attachment C) and these patients were also included in the retrospective 
part. This form was completed by reading the medical records of the patients at the ward. When 
these were incomplete the author searched the online medical records and asked for the 
complete medical records in the medical records archive. 19 patients were at the ward when the 
author was present and 18 of these were included in the study and completed the patient form. 
One patient was discharged before the author had found a relative of the patient or a nurse that 
could translate and ask the patient to participate (Attachment D). 
When calculating the statistical significant correlations between smoking, alcohol habits and 
malignant disease, the patients were grouped in two different groups based on if they were 
smoking or not and if they consumed alcohol or not. This was due to the small number of 
patients in the study. 
 
4.3 Statistical methods 
The data were transcribed into computerized versions of the collection forms. The data that 
would be used for creating graphs and be presented in the scientific report were transcribed into 
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Statistical Package for Social Sciences (SPSS). Age groups were made using “transform and 
recode” into groups of < 40, 41 to 65 and > 65 years. Groups of different aetiology were made 
dividing them into 12 categories: hilar cholangiocarcinoma, distal cholangiocarcinoma, carcinoma 
gallbladder, carcinoma head of pancreas, carcinoma pancreas, ampullary and periampullary 
carcinoma, cholangitis, choledocholithiasis, cholecystitis, pancreatitis and bile duct injury. The 
functions “analyse – descriptive statistics - descriptives and frequencies” were used in SPSS. Bar 
graphs, cross tables and the function to custom tables were used. Excel were used for 
calculations using the functions “mean” and “antal.om”. Tables were made in Excel. For the 
prospective data the patients were divided into categories of either currently smoking or not 
currently smoking as well as alcohol consumption or no alcohol consumption, which were 
created using excel. MATLAB were used to calculate statistical significance by two sample t-test 
and correlations. Regression analysis was conducted using MATLAB. Statistical significant p-
value was considered when p < 0.05.  
5. Ethics 
The study adhered to the principles of the Helsinki Declaration. The author gained approval of 
the institutional review board (IRB) at the institute of medicine (Attachment E). The author 
influenced in no way the medical care of the patients. The patients informed consent was gained 
by explaining to the patients about the study, asking them to give consent and complete the 
patient form for all patients taking part in the prospective part of the study. There were very 
general questions in the form and no intrusive questions.  
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6. Results 
6.1 Retrospective data 
The total number of patients with obstructive jaundice was 110. There were 61 (55.5%) females 
and 49 (44.5%) males. The mean age of the study population was 55 years. Most patients were 
over 40 years old, 83 (75.45 %) patients. Most patients were in the age group of 40-65 years old,         
59 (53.6%) patients. The mean age of the malignant cases was 61 years (±3.5, 95% confidence 
interval) compared to the mean age of benign cases that was 47 years (±4.4). There were on 
average a 14-year age difference between the groups which is statistically significant p= 3.13e-06. 
About half of the patients had a malignant cause 56 (50.9%) to the disease and half had a benign 
cause 52 (47.3%). The patients under 40 years of age with a malignant cause to the disease 
consisted of 4 (3.6 %) patients in total. The group of patients below 65 years with a benign cause 
were 47 (42.7%) in total. (Table 1 and Figure 1) 
. 
. 
 
Table 1: Table over sex, age group and malignant or benign cause of obstructive 
jaundice of the retrospective part of the study with 110 patients in number and 
percentage. 
 
Total number (%) Malignant cases (%) Benign cases (%) Unknown cases (%)
Sex Women 61 (55.5%) 28 (45.9%) 32 (52.5%) 1 (1.6%)
Men 49 (44.5%) 27 (55.1%) 20 (40.8%) 1 (2.0%)
Age group Under 40 27 (24.5%) 4 (14.8%) 22 (81.5%) 1 (3.7%)
Distribution 41 to 65 59 (53.6%) 33 (55.9%) 25 (42.4%) 1 (1.7%)
(Years) 66 and over 24 (21.8%) 19 (79.2%) 5 (20.8%) 0 (0%)
Mean age 55 61 47 49
Causes of obstructive jaundice 110 (100%) 56 (50.9%) 52 (47.3%) 2 (1.8%)
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The most common cause of obstructive jaundice was distal cholangiocarcinoma, affecting 15.5% 
(±6.8%, 95% confidence interval) of the patients. The second most common cause was 
pancreatitis, with 13.6% (±6.4%). This order is however not statistically significant.  Among the 
malignant causes distal cholangiocarcinoma 17 (15.5%), hilar cholangiocarcinoma 12 (10.9%) 
and carcinoma of the gallbladder 10 (9.1%) were common causes. Of the benign causes 
pancreatitis 15 (13.6%), cholangitis 12 (10.1%), choledocholithiasis 7 (6.4%) and bile duct injury 
7 (6.4%) were the most common causes (Table 2). 
 
Figure 1: Bar graph of age group distribution over different causes of obstructive jaundice, malign causes to the left 
side and benign causes to the right side, for the retrospective part of the study with 110 patients. 
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The share of patients having Carcinoma of the Pancreas as a cause was 6.4%( ±4.6%, 95% 
confidence interval), while as cholangiocarcinoma was 26.4 % (±8.3%), this difference is 
statistically significant (p=1.69e-04). 
Carcinoma of the gallbladder as a cause to obstructive jaundice was more common among 
females and ampullary and periampullary cancer was only found among males (Figure 2). 
 
Table 2: Table with different aetiology in number and percentage, retrospective study 
 
Figure 2: Bar graph of proportions of women and men related to diagnosis, retrospective part of the study 
Causes of obstructive jaundice Number (percentage)
Hilar cholangiocarcinoma 12 (10.9%)
Malignant cause Distal cholangiocarcinoma 17 (15.5%)
(n=56) Carcinoma gallbladder 10 (9.1%)
Carcinoma head of pancreas 6 (5.5%
Carcinoma pancreas 1 (0.9%)
Ampullary and Periampullary 
Carcinomas 9 (8.2%)
Cholangitis 12 (10.1%)
Benign cause Choledocholithiasis 7 (6.4%)
(n= 52) Cholecystitis 6 (5.5%)
Pancreatitis 15 (13.6%)
Bile duct injury 7 (6.4%)
Others 6 (5.5%)
Unknown cause              
(n=2) Unknown 2 (1.8%)
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The presenting symptoms of obstructive jaundice were (percentage of patients having each 
symptom): jaundice (79%), other symptoms (58%), RUQ - pain (41%), itching (38%) and 
anorexia/loss of appetite/loss of weight (38%) and epigastric pain (37%) (Table 3).  
 
 
 
 
 
 
 
Some symptoms are significantly positively related to malign disease, namely; itching (p= 1.04 e-
05), clay-coloured stool (p=0.0022), anorexia/loss of appetite/loss of weight (p=0.00016), and 
dark urine (p=0.016). There is a significantly negative correlation between fever with chills and 
rigor and malignant disease, (p=0.027). There are no significant differences between different sex 
and symptoms or difference between sex contra malign and benign cause. There is a positively 
significant correlation between age and itching, c=8.7 and p=0.0057. There is a significant 
positive correlation between age and anorexia, c=8.3 and p=0.0094. 
 
Table 3: with symptoms of obstructive jaundice in percentage of patients for 
each symptom, of the retrospective part of the study.  
Symptoms Total (%)
Jaundice 87 (79.1%)
Right Upper Quadrant pain 45 (40.9%)
Epigastrial pain 41 (37.3%)
Itching 42 (38.2%)
Fever with chills and rigor 13 (11.8%)
Fever without chills and rigor 37 (33.6%)
Clay coloured stool 30 (27.3%)
Anorexia/loss of appetite/loss of weight 42 (38.2%)
Dark urine 29 (26.4%)
Other 64 (58.2%)
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6.2 Prospective cross-sectional data 
The total number of patients that were included were 18. There were 11 (61.1%) women and      
7 (38.9%) men. The mean age was 51.5 years, this is not significantly different from the 
retrospective study. The youngest patient was 21 years old and the oldest was 73 years old. 50% 
of the patients were between 45 and 65 years. There were 10 (55.6%) malign cases, 7 (38.9%) 
benign cases and 2 (11.1%) patients with unknown cause of obstructive jaundice (Table 4). 
 
The mean age of the patients with malign cause were 62.4 years (±5.3, 95% confidence interval, 
not significantly different from the overall mean above) and 34.3 years (±6.1, borderline 
significantly different from the overall mean above, p=0.069) for those with benign cause, a 
difference of 28 years in mean difference. The difference is statistically significant (p= 7.9e-06). 
The mean age, for those with unknown cause, was 48.5 years. There were no malignant cases 
below 40 years of age. Out of 6 benign cases, 5 were below 40 years of age. All the patients over 
65 years of age had a malignant cause to the disease.  
Table 4: Table over sex, age group and malignant or benign cause of obstructive jaundice of the retrospective part of the study, with number 
and percentage. 
 
Total number (%) Malignant cases (%) Benign cases (%) Unknown cases (%)
Sex Women 11 (61.1%) 4 (22.2%) 6 (33.3%) 1 (5.6%)
Men 7(38.9%) 6 (33.3%) 0 (0%) 1 (5.6%)
Age group Under 40 6 (33.3%) 0 (0%) 5 (27.8%) 1 (5.6%)
Distribution 41 to 65 9 (50.0% 7 (38.9%) 1 (5.6%) 1 (5.6%)
(years) 66 and over 3 (16.7%) 3 (16.7%) 0 (0%) 0 (0%)
Mean age 51.5 62.4 34.3 48.5
Causes of obstructive jaundice 18 (100%) 9 (50.0%) 7 (38.9%) 2 (11.1%)
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There were only females that had bile duct injury and pancreatitis as a cause. Only men had 
periampullary and ampullary carcinoma and carcinoma gallbladder as a cause. Hilar 
cholangiocarcinoma is the most common reason for obstructive jaundice followed by bile duct 
injury as the second most common (Table 5). 
The presenting symptoms noted in the medical journals were jaundice 66.7 %, itching 61.1%, 
fever without chills and rigor 38.9%, anorexia/weight loss/loss of appetite 38.9%, other 
symptoms 38.9%, RUQ - pain 33.3%, clay-coloured stool 33.3%, dark urine 22.2%, epigastric 
pain 16.7% and fever with chills 5.6%. 
Table 5: Table with different aetiology in number and percentage, prospective cross-sectional study 
 
Causes of obstructive jaundice Number (%)
Hilar cholangiocarcinoma 5 (27.8%)
Malignant cause Distal cholangiocarcinoma 1 (5.6%)
(n=9) Carcinoma gallbladder 1 (5.6%)
Carcinoma head of pancreas 0 (0%)
Carcinoma pancreas 0 (0%)
Ampullary and Periampullary Carcinoma 2 (11.1%)
Cholangitis 1 (5.6%)
Benign cause Choledocholithiasis 0 (0%)
(n=7) Cholecystitis 0 (0%)
Pancreatitis 2 (11.1%)
Bile duct injury 3 (16.7%)
Others 1 (5.6%)
Unknown cause Unknown 2 (11.1%)
(n=2)
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 The symptoms from the patient forms were jaundice 83.3%, itching 77.8%, dark urine 61.1%, 
RUQ - pain 55.6%, anorexia/weight loss/loss of appetite 44.4%, clay-coloured stool 38.9%, and 
fever with chills and rigor 33.3% (Table 6). 
More patients themselves noted itching in the patient form compared to what was written in the 
medical records, 77.8 % compared to 61.1 %, p= 0.0093. The patients noticed having dark urine 
in 61.1% of the cases compared to 22.2 % which was noted in the medical records, p=0.0041. It 
was near significant, p=0.10, that 83.3 % says they have had jaundice compared to 66.7% in the 
medical records. There are no significant differences in presenting symptoms between sexes.  
However, there are a near significant difference in that fewer women report itching in the patient 
forms compared to men, p=0.078 and near significant that fewer women report dark urine than 
men, p=0.098. All men with known cause (n=6) in the prospective study have a malignant cause, 
compared to that 40% of the women have a malignant cause, the difference is statistically 
significant, p=0.014.  
There are near significant positive correlations between RUQ - pain and dark urine, p=0.0725 
and RUQ - pain and fever, p=0.1045. A positive significant correlation between itching and 
jaundice exists, c=0.43 and p=0.0448. Itching and anorexia has a positive correlation, c=0.4 and 
p=0.0448. There are near significant positive correlations between itching and clay-coloured 
stool, p=0.078 and between itching and dark urine, p=0.1038. Fever and anorexia are positively 
correlated, c=0.525 and p=0.0172. There is a near significant positive correlation between fever 
Table 6:  Table with symptoms of obstructive jaundice, for the prospective part of the study, from both the medical records and from 
the patient forms. 
 
Symptoms Medical records, n (%) Patient forms, n (%)
Jaundice 12 (66.7%) 15 (83.3%)
Right Upper Quadrant  pain 6 (33.3%) 10 (55.6%)
Itching 11 (61.1%) 14 (77.8%)
Fever with chills and rigor 1 (5.6%) 6 (33.3%)
Clay coloured stool 6 (33.3%) 7 (38.9%)
Anorexia/loss of apetite/loss of weight 7 (38.9%) 8 (44.4%)
Dark urine 4 (22.2%) 11 (61.1%)
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and clay-coloured stool, p=0.0974. Dark urine and anorexia are positively correlated c=0.475 
and p=0.0417.  
Usage of alcohol and smoking are positively correlated with malign cause. Usage of alcohol with 
malign cause, c=0.67 and p=0.0035. Smoking with malign cause, c=0.6 and p=0.014. There is a 
strong correlation between usage of alcohol and smoking c=0.68 and p=0.0027. There is a 
positive correlation between smoking and RUQ - pain, c=0.475 and p=0.0417. Alcohol and 
RUQ – pain is positively correlated c=0.575 and p=0.0125. It is near significant that smoking is 
positively correlated to dark urine, p=0.0976. It is near significant that alcohol is positively 
correlated with jaundice, p=0.1.  
7. Discussion  
7.1 Retrospective data 
Due to lack of research and published articles, there was only three articles published which 
could be accessed and therefore those three articles are the foundation of the following 
discussion.  
This study found that there was a mean age of 61 years for the malignant cases compared to the 
mean age of the benign cases that were 47 years. There was on average a 14-year age difference. 
The correlation between malignant cause and older age is described in comparative studies as 
well. Gupta found the mean age of malignant cases to be 68.5 years and the mean age of benign 
cases to be 42.7 years (Gupta, Singh, Goel & Tank, 2017). Siddique found the mean age of 
malignant cause to be 56.4 years and the mean age of benign cause to be 42 years (Siddique, Ali, 
Mirza, Jamil, Ehsan, Latif & Malik, 2008). Chalya found the mean age of malignant cases to be 
58.6 years and that of benign cases to be 42.6 years (Chalya, Kanumba and Mchembe, 2018). The 
result of this study is supported by previous studies that it is more common for older people to 
have a malignant cause whereas younger people more often have a benign cause.  
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About half of the patients had a malignant cause to the disease and half had a benign cause 
indicating that both causes could be equally common and the benign cause being more common 
than indicated in previous studies. Other studies have found that the malignant cause was 
prevalent in 56.6% of cases (Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008) and another 
study found it in 63.9% of cases (Gupta, Singh, Goel & Tank, 2017). These two studies had a 
lesser number of patients 36 (Gupta, Singh, Goel & Tank, 2017) and 60 (Siddique, Ali, Mirza, 
Jamil, Ehsan, Latif & Malik, 2008) compared to this study with 110 patients, possibly explaining 
the differences. In a third study, 58.6 % of the patients had a malignant cause to the disease 
(Chalya, Kanumba and Mchembe, 2018). This study had included 116 patients over the course of 
4 years in a hospital with over 950 beds, indicating that there should have been more patients 
with obstructive jaundice. There is a possibility that patients with a malignant cause are more 
easily diagnosed with obstructive jaundice, due to them having a usually longer hospital stay, 
more chronic symptoms and usually need invasive methods of treatment as compared to patients 
with a benign obstruction which could even resolve on its own or heal with conservative 
treatment. Therefore, making them easier to include in the studies. The study made in India is a 
retrospective study where they have included all patients positively diagnosed with extrahepatic 
obstructive jaundice, over the course of one year (Gupta, Singh, Goel & Tank, 2017). What is 
striking is that they only include patients that have received a diagnosis, possibly losing many 
patients that are not diagnosed, as is usually the case with these patients. The study made in 
Tanzania also include patients with a clinical diagnosis of obstructive jaundice (Chalya, Kanumba 
and Mchembe, 2018). In this study made in Nepal, with 110 patients, there was a minority that 
had “obstructive jaundice” written in their medical records. Indicating that not all patients with 
obstructive jaundice are given the diagnosis, possibly explaining the difference between this 
study and previous studies. 
The most common cause was cholangiocarcinoma in this study compared to other studies were 
carcinoma head of pancreas was the most common malignant cause, described to be between  
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30-65% of malignant causes compared to only 10.7% in this study. This could be due to 
different cancers having different prevalence in different populations. However, the patterns of 
care-seeking at the tertiary care hospital might vary depending on i.e. economic situation. The 
patients having cholangiocarcinoma and seeking care at T.U.T.H. might be a group of patients 
with a good economy, quite wealthy, coming as a last resort after already seeking care at private 
hospitals making this group amounting to a larger number of patients than what would be 
expected. Probably there are many patients with more common cancers like carcinoma of the 
pancreas that are seeking care only at the local hospitals in different parts of the country and due 
to their economic situation newer seek T.U.T.H. for advanced care. Thus explaining the large 
number of patients with cholangiocarcinoma compared to carcinoma of the pancreas at 
T.U.T.H. 
The mean age of the study population were 55 years which are supported by two other studies 
that found the mean age to be 49.5 years (Gupta, Singh, Goel & Tank, 2017) and 56.4 years 
(Chalya, Kanumba and Mchembe, 2018) respectively. Most patients were over 40 years old (75.5 
%). Most patients were in the age group of 40-65 years (53.6%) which indicates that the patients 
are younger compared to in the study made by Gupta that described more than 50% of cases to 
be between 55 and 75 years old (Gupta, Singh, Goel & Tank, 2017). 
There were 55.5 % females and 44.5 % males strengthening previous results that obstructive 
jaundice is more common in females than in males. This have been found in previous studies 
which have found 66.7% females and 33.33% males respectively (Siddique, Ali, Mirza, Jamil, 
Ehsan, Latif & Malik, 2008) and 56.9% females and 43.1 % males (Chalya, Kanumba and 
Mchembe, 2018). In opposition another study has found the proportions to be 44.4% females 
and 55.6% males (Gupta, Singh, Goel & Tank, 2017). That a majority of patients are female 
seems reasonable due to that it is more common for females to suffer from gallstones, 
predisposing to both malignant and benign causes of obstructive jaundice.  
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The most common presentation of obstructive jaundice was jaundice (79.1%), other symptoms 
(58.2%), RUQ - pain (40.9%), itching (38.2%) and anorexia/loss of weight/loss of appetite 
(38.2%) and epigastric pain (37.3%). According to Gupta the most common symptoms were 
jaundice (91.7%), loss of appetite (77.8%) and pain abdomen (75%) (Gupta, Singh, Goel & 
Tank, 2017). The results are strikingly different in prevalence. The high percentage of patients 
with loss of appetite (77.8%), in the study by Gupta, can be understood when put in relation to 
the large proportion of patients with malignant disease, 63.9 % in their study. There is a 
difference in how many patients suffer from itching, in this Nepalease study 38.2% compared to 
in the other studies there are 66.7% (Gupta) and 55% (Siddique). Itching should be correlated to 
jaundice and bilirubin levels. Total bilirubin and itching is positively correlated, C=112,2, with 
p=0.0021. It could be that it differs how regularly the patients are specifically asked about 
itching, this might have been overlooked. In comparison between the prospective cross-sectional 
study where 77.8 % of the patients describe itching (when asked specifically about itching), 
38.2% in the retrospective seems low. 
Clay-coloured stool (p= 0.0035) and anorexia/loss of weight/loss of appetite (p=0,0012) were 
significantly more common in malignant disease in this study and was also found in the study 
made by Siddique (Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008). In opposition to that 
study, this study also found that itching (p= 3.069 x 10^-5), and dark urine (p=0.0083) was more 
common in malignant disease. 
In this study there were not any correlations regarding pain and malignant or benign disease. 
However, Siddique found that RUQ - pain was more commonly seen in benign disease 
(Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008).  
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7.2 Prospective cross-sectional data 
The proportions of 61.1% women and 38.9% men in this study were similar to the proportions 
of 66.7% females and 33.33% males described in a study made in Pakistan (Siddique, Ali, Mirza, 
Jamil, Ehsan, Latif & Malik, 2008). This stands in opposition to 44.4% females and 55.6% males 
described in a study made in Uttar Pradesh, a state in India bordering to Nepal (Gupta, Singh, 
Goel & Tank, 2017).  However, there were a majority of females in the larger retrospective study 
as well, supporting that females are more often suffering from obstructive jaundice.   
Half of the patients were between 45 and 65 years old, which corresponds with the results of the 
retrospective study. Another study found that more than 50% of the patients were in the age 
group of 55-75 years (Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008) also indicating that 
most patients are middle-age or above. 
There were 55.6% malign cases, 38.9% benign cases and 11.1% of cases with unknown cause to 
the disease, this proportion corresponds well to other studies which have found that the 
malignant cause was prevalent in 56.6% of cases (Siddique, Ali, Mirza, Jamil, Ehsan, Latif & 
Malik, 2008) and another study found it in 63.9% of cases (Gupta, Singh, Goel & Tank, 2017). 
The mean age of the patients with malign cause were 62.4 years and 34.3 years for those with 
benign cause. A difference of 28 years in mean age difference. This comes close to 25.8 years as 
mean difference which Gupta found, the mean age of malignant cases to be 68.5 years and the 
mean age of benign cases to be 42.7 years (Gupta, Singh, Goel & Tank, 2017). Siddique found 
the mean age of malignant cases to be 56.4 years and the mean age of benign cases to be 42 years 
(Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008) which is also in the same area, 
supporting that it exists a real difference between the two different patient groups and that the 
older patients more often have a malignant cause to the disease. 
Hilar cholangiocarcinoma is the most common cause which corresponds with the retrospective 
part of the study and stands in opposition to previous studies by Siddique and Gupta. In both 
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other studies carcinoma head of pancreas was much more common, it was the most common 
cause with 53.8% (Gupta, Singh, Goel & Tank, 2017) and the second most common cause with 
30.0% (Siddique, Ali, Mirza, Jamil, Ehsan, Latif & Malik, 2008) as opposed to  0% in this 
prospective study. This could be due to the small size of the study, there were 5.5% of patients 
in the retrospective study with a larger study size. Still there is a large difference which could 
indicate that carcinoma head of pancreas is less common in Nepal or that it is due to the 
relatively small size of the studies 36 patients in the study by Gupta and 60 patients in the study 
by Siddique. This indicates that carcinoma head of pancreas is less common in Nepal compared 
to in India and Pakistan. Cholangiocarcinoma was the cause in 11.7% (Siddique, Ali, Mirza, 
Jamil, Ehsan, Latif & Malik, 2008) and 11.1%  of the cases (Gupta, Singh, Goel & Tank, 2017) in 
the other studies compared to 26.4 % in this study. This difference could be attributed to the 
possibility that cholangiocarcinoma is more common in Nepal or due to the different care-
seeking patterns of the patients. 
The patients report having the symptoms themselves more frequent than what is written in the 
medical records and this is true for all of the symptoms. It is possible that this is solely because 
they might be measuring different things. In the patient form the patients are asked to indicate 
which symptom/symptoms they have had or has while the medical journals quite often only 
describe the chief complaint at the present time and the complete history of the disease with 
symptoms can be overlooked, especially if the patient already have received a diagnosis and are 
given palliative treatment. Then it appears that it is not interesting enough to describe for 
example if the patient have/have had jaundice, itching or dark urine or to order lab works to 
prove the high bilirubin levels, if this is already known and the patient is hospitalized for a 
reinsertion of a PTBD for example. One other interpretation is that the patients are not always 
asked if they have or have had those symptoms, asked about the course of the disease, listened 
to or the information is simply not written down in the medical journals.  
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7.3 Methodological considerations  
The study was designed by the author, an outsider, not familiar with the setting, how things 
worked at the hospital and who could not speak the local language. This was a disadvantage and 
it had a negative effect on the study design and the possibility to interact with patients and staff. 
Overall the study design was good enough to access the data required to answer the basic 
questions of aetiology, sex and age as well as symptoms. All this information was accessible in 
the medical journals. It was more complicated to access other data such as data concerning 
symptoms, treatment and diagnostic methods. The patient form was made in a simple enough 
manner and most patients managed to complete the form, a few did however struggle and 
needed guidance. This could be since several of the patients themselves was illiterate and their 
family completed the form, or they managed by the help of a nurse. Most of the patients did not 
complete the form themselves but their family did that for them. Since the families are close, the 
family stays with the patient every day, buys the needed medications and other health 
expenditures themselves, they are trustworthy to complete the forms since they know everything 
about the patient’s history. However, since the patients did not complete the forms themselves 
there is a risk that some data are lost on the way. Most patients stayed in rooms with several 
other patients and this meant that everything could be overheard and there was no privacy. 
Another downside to the prospective study was the fact that the author could only stay for a 
couple of weeks, this meant that only 18 patients could be included. Preferably, to do this kind 
of study, the person caring for the patients and working at the hospital should be the one doing 
the study. This would mean that the person could include patients during a longer period, using a 
more elaborate patient form or gathering information themselves by examination and 
interviewing the patients about symptoms. Since the author had limited time, there was no time 
to evaluate the form and change it according to the needs and questions arising. The author was 
limited to the medical journals which varied in quality. The limitations were less when doing the 
retrospective part of the study since that part was based solely on the medical records and the 
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information that was there were used. The limitation here was to find as many patient medical 
records as possible, to make certain that the included patients were representative patients, as 
medical records were lost, and the online records were not complete. The medical records varied 
in quality. 
The admittance books posed a challenge since they were hand written and often there were 
miswritings of the patient numbers making it impossible to find the right patient medical records 
in the archive, since they were organised after patient number.  
The biggest challenge was to decide upon which patients to include or exclude. Quite often there 
were information lacking in the medical journals concerning at least one of the three criteria’s 
that determined the diagnosis. The author could not find any discussion in the previous studies 
where it was described how they dealt with questionable cases and where exactly they 
determined were the border was of what was and what was not an obstruction. Most patients, 
determined to have obstructive jaundice, newer received a diagnosis of obstructive jaundice in 
their medical records but going through their records the author could understand that that was 
the case and include them in the study. To do this kind of study it was necessary to decide upon 
the diagnosis based on lab works, clinical data and radiological data. The study would have a 
completely different population if only those patients that had obstructive jaundice written in 
their records were included.   
Some questions remain, those that were aimed at investigating how the patients were diagnosed, 
methods of treatment and purpose of the treatment could not be answered in this study. There 
were not enough data in the medical records to answer these questions. There were data missing 
concerning radiological method as well as methods of treatment and purpose. There were not a 
great enough quantity of information regarding ERCP and complications in the medical records. 
If the author would have tried to answer these questions as well, the study would have needed to 
be reshaped and have grown immensely. To be able to collect data about treatment methods of 
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stenting with ERCP or PTBD and its complications it would have been necessary to go through 
the radiology lab, using their records or preferably by doing a prospective study in combination 
with the two departments. The next step would have been to perform a comparison of both 
techniques and looking at patient quality of life or patient satisfaction and survival. This would 
be very interesting and the hospital, the hospital staff and patients would have benefited of 
having these two methods evaluated. Since a great part of the world has already abandoned 
PTBD in preference of ERCP stenting, for the benefit of the patients with increased survival 
rates (Sugiyama et al., 2014). This will probably be the next step in Nepal as well over the course 
of the years. 
Regarding the first presenting symptom, this data could not be properly obtained since the first 
presenting symptom was not generally written down in the records especially not for the patients 
with malign cause. The patients usually already had the diagnosis of cancer and obstructive 
jaundice when they were admitted at the ward which meant that the history of the present illness, 
of this hospitalization was written down but more rarely the symptoms of the start of the disease 
itself. This meant that data concerning the first presenting symptom was not accessible by this 
method. Data concerning length of hospitalisation could not be retrieved in all cases and was 
often missing which meant that the author could not answer that question. 
Discussing the symptoms, it would be interesting to describe the course the symptoms took. 
This was something the author had wished to do but it turned out to be impossible since this 
was not written in the patient records frequent enough. The ideal would be, for the surgeon 
working at the ward to perform a prospective study over the course of a year. Including all the 
patients going through the ward with the help of a member of every surgical team at the wards 
and composing a more detailed questionnaire or going through the medical records, talking to 
the patients and examining the patients themselves. This would suffice to collect better data of 
symptoms and time course.  
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Since cholangiocarcinoma seemed to be more common, compared to in neighbouring countries, 
this could be an interesting topic to explore further. It is important to remember that T.U.T.H is 
a referral hospital in Nepal, thus explaining some part of the high number of patients with 
cholangiocarcinoma at the surgical ward but it is probably not the only factor. It would be 
interesting to investigate if this relatively large number of patients, with cholangiocarcinoma, 
could be explained by considering the pattern of which the patients were seeking care. If the 
patterns of seeking care does not explain this difference other explanations must be considered. 
If there are any specific risk factors or genetics that are unique for Nepal. Further studies, 
describing the course of the disease, survival time and complications would be essential in the 
continuing research field since there are no register of cancer patients in Nepal.  
8.Conclusion 
 
As previous studies have shown; this study confirms that older people more often have a 
malignant cause to obstructive jaundice opposed to younger patients. As opposed to other 
studies in neighbouring countries, this study indicates other proportions of the malignant 
spectrum, with distal cholangiocarcinoma as the leading cause. It could be due to different 
patterns of care-seeking due to i.e. economic reasons. However, it could indicate that the 
malignant causes of obstructive jaundice vary in different countries and that cholangiocarcinoma 
might be more common in Nepal compared to in neighbouring countries.  
This study serves as an important first step in the continuing exploration of the research field.  
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9. Populärvetenskaplig sammanfattning på svenska 
Obstruktiv gulsot – orsaker och symptombild Nepal 
Obstruktiv gulsot är ett tillstånd då det föreligger en obstruktion i gallvägarna som kan ge gulsot, 
klåda och vitfärgad avföring som symtom. Det kan bero på många olika orsaker, både maligna 
och benigna. Det är en relativt outforskad gren inom medicinvetenskapen, särskilt i 
utvecklingsländer som Nepal. Förhoppningen var att den här studien skulle bidra till att utveckla 
sjukvården och bidra till mer forskning i Nepal. Syftet med projektet var att kartlägga och 
beskriva de olika orsakerna till sjukdomen och symtom samt relatera detta till olika faktorer som 
ålder och kön. Studien baseras på patienter från en kirurgavdelning på ett sjukhus i Kathmandu. 
Studien bestod utav två delar. 110 patienter deltog i den tillbakablickade delen som baserades på 
deras medicinska journaler. Utav dessa svarade 18 patienter även på ett patientformulär. Med 
stigande ålder var det vanligare att patienterna hade en malign orsak till sjukdomen, skillnaden 
bestod i medel på 28 år. I den här studien var den vanligaste orsaken kolangiokarcinom (en 
cancer som utgår ifrån gallvägarna) som orsak till obstruktiv gulsot vilket skiljer sig från andra 
jämförbara studier i grannländer. Det tyder på att patienternas sökmönster är annorlunda eller att 
kolangiokarcinom som orsak till obstruktiv gulsot kan vara betydligt vanligare i Nepal jämfört 
med i grannländerna. 
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12. Appendices 
12.1 Attachment A: Patient form 
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12.2 Attachment B: Informed consent 
 
 
Signature (or Thumb impression) of the Subject/Legal Guardian: 
_____________                                              
 Date: _____/_____/______  Signatory’s Name: _____/_____/______ 
______________________________________________________  
Signature of the Investigator: ____________________________ Date: _____/_____/______ 
Study Investigator’s Name: __________________________________________________ 
Signature of the Witness ______________________ Date:_____/_____/_______  
Name of the Witness: _______________________________________________________ 
MODEL INFORMED CONSENT FORM IN ENGLISH  
Department of GI and General surgery, 
Tribhuvan University Institute of Medicine, Kathmandu, Nepal, 
Study Title: Causes of obstructive jaundice, presentation and management – a clinical study at Tribhuvan 
University Teaching Hospital, Kathmandu, Nepal. 
Study Number: Subject’s Initials: _______________  
Subject’s Name:_______________  
Date of Birth / Age: _________________                         
 
Please do initial in box (Subject)  
(i)  I confirm that I have read and understood the information sheet and consent form dated ___ 
for the   above study and have had the opportunity to ask questions.  
[    ]  
(ii)  I understand that my participation in the study is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights being affected.  
[ ]  
(iii)  I understand that the researchers and the IRB and other regulatory authorities will not need 
my permission to look at my health records both in respect of the current study and any 
further research that may be conducted in relation to it, even if I withdraw from the trial. I 
agree to this access. However, I understand that my identity will not be revealed in any 
information released to third parties or published.  
[    ]  
 I agree not to restrict the use of any data or results that arise from this study provided such a 
use is only for scientific purpose(s)  
[    ]  
(v)  I agree to take part in the above study.  [    ]  
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12.3 Attachment C: Collection form for both retrospective and 
prospective cross-sectional part 
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12.4 Attachment D: Flow-chart for the retrospective and the 
prospective part 
 
 
 
 
 
 
 
 
 
Admittance book    
Annex-1  
930 patients 
 
 
 
Admittance book            
Male Surgical Ward 
606 patients 
Admittance book           
Female Surgical Ward 
319 patients 
230 patients with 
relevant diagnosis’s 
169 patients with 
relevant diagnosis’s 
104 patients with 
relevant diagnosis’s 
55 patients with 
obstructive jaundice 
41 patients with 
obstructive jaundice 
33 patients with 
obstructive jaundice 
129 patients 
119 patients 
98 patients 
164 not 
obstructive 
jaundice 
11 not 
found 
11 not 
found 
117 not 
obstructive 
jaundice 
61 not 
obstructive 
jaundice 
10 not 
found 
10 
duplicats 
Missing data        
3 
18 
inhospitalisations 
for the same 
patients 
700 
unrelevant  
437 
unrelevant 
110 patients 
18 patients 
12 patients 
included 
19 patients 
20 patients 
1 lost 
1 
duplicate 
Prospective part 
Retrospective 
part 
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12.5 Attachment E: Ethical approval 
